The classic website will no longer be available as of June 25, 2024. Please use the modernized
Working… Menu

Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity (SELECT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03574597
Recruitment Status : Completed
First Posted : July 2, 2018
Last Update Posted : April 2, 2024
Information provided by (Responsible Party):
Novo Nordisk A/S

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : June 21, 2023
Actual Study Completion Date : June 29, 2023
Publications of Results:
Publications automatically indexed to this study by Identifier (NCT Number):